These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3732336)

  • 1. The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
    Möller HJ; Kissling W; Bottermann P
    Eur Arch Psychiatry Neurol Sci; 1986; 235(5):263-8. PubMed ID: 3732336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the dexamethasone suppression test predictive of response to specific antidepressant treatment in major depression?
    Steardo L; Barone P; Monteleone P; Iovino M; Cardone G
    Acta Psychiatr Scand; 1987 Aug; 76(2):129-33. PubMed ID: 2890265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A; Frecska E; Rihmer Z; Arató M
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial dexamethasone suppression tests in psychiatric illness: Part II. A study in major depressive disorder.
    Baumgartner A; Gräf KJ; Kürten I
    Psychiatry Res; 1986 May; 18(1):25-43. PubMed ID: 3737786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test and response to placebo.
    Peselow ED; Lautin A; Wolkin A; Rohrs C; Novatt A; Siekierski J; Rotrosen J
    J Clin Psychopharmacol; 1986 Oct; 6(5):286-91. PubMed ID: 3534005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH; Jackson HJ; Joshua SD; Burgess PM
    Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and antidepressant response in major depression.
    Simon JS; Evans DL; Nemeroff CB
    J Psychiatr Res; 1987; 21(3):313-7. PubMed ID: 3681765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
    Benkelfat C; Poirier MF; Léouffre P; Gay C; Löo H
    Can J Psychiatry; 1987 Apr; 32(3):175-8. PubMed ID: 3471304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.
    Hubain PP; Simonnet MP; Mendlewicz J
    Neuropsychobiology; 1986; 16(2-3):57-60. PubMed ID: 3587576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of the dexamethasone suppression test in endogenous depressive patients.
    Lu RB; Ho SL; Huang HC; Lin YT
    Neuropsychopharmacology; 1988 May; 1(2):157-62. PubMed ID: 3251496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J; Plocka M
    J Affect Disord; 1992 Feb; 24(2):87-91. PubMed ID: 1541770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
    Yeragani VK
    Can J Psychiatry; 1990 Mar; 35(2):128-32. PubMed ID: 2138504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in residual schizophrenia with depression.
    Munro JG; Hardiker TM; Leonard DP
    Am J Psychiatry; 1984 Feb; 141(2):250-2. PubMed ID: 6691488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic and serotoninergic depression?
    Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
    J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE; Ettigi P
    Clin Pharm; 1983; 2(6):538-45. PubMed ID: 6140096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression test in schizophrenia. A study and review.
    Asnis GM; Eisenberg J; Lemus CZ; Halbreich U
    Neuropsychobiology; 1986; 15(3-4):109-13. PubMed ID: 3785640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.